At a glance
This page provides table of contents for the 2024 U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC), which comprises recommendations for health care providers for the use of specific contraceptive methods by persons who have certain personal characteristics or medical conditions.
Table of contents
- Summary for U.S. MEC, 2024
- Table of Contents
- Introduction
- Methods
- Keeping Guidance Up to Date
- How to Use This Document
- Appendix A: Summary of Changes from U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
- Appendix B: Classifications for Intrauterine Devices
- Personal characteristics and reproductive history
- Cardiovascular disease
- Renal disease
- Rheumatic diseases
- Neurologic conditions
- Depressive disorders
- Reproductive tract infections and disorders
- HIV
- Other infections
- Endocrine conditions
- Gastrointestinal conditions
- Respiratory conditions
- Hematologic conditions
- Solid organ transplantation
- Drug interactions
- Personal characteristics and reproductive history
- Appendix C: Classifications for Progestin-Only Contraceptives
- Personal characteristics and reproductive history
- Cardiovascular disease
- Renal disease
- Rheumatic diseases
- Neurologic conditions
- Depressive disorders
- Reproductive tract infections and disorders
- HIV
- Other infections
- Endocrine conditions
- Gastrointestinal conditions
- Respiratory conditions
- Hematologic conditions
- Solid organ transplantation
- Drug interactions
- Personal characteristics and reproductive history
- Appendix D: Classifications for Combined Hormonal Contraceptives
- Personal characteristics and reproductive history
- Cardiovascular disease
- Renal disease
- Rheumatic diseases
- Neurologic conditions
- Depressive disorders
- Reproductive tract infections and disorders
- HIV
- Other infections
- Endocrine conditions
- Gastrointestinal conditions
- Respiratory conditions
- Hematologic conditions
- Solid organ transplantation
- Drug interactions
- Personal characteristics and reproductive history
- Appendix E: Classifications for Barrier Methods
- Personal characteristics and reproductive history
- Cardiovascular disease
- Renal disease
- Rheumatic diseases
- Neurologic conditions
- Depressive disorders
- Reproductive tract infections and disorders
- HIV
- Other infections
- Endocrine conditions
- Gastrointestinal conditions
- Respiratory conditions
- Hematologic conditions
- Solid organ transplantation
- Drug interactions
- Personal characteristics and reproductive history
- Appendix F: Classifications for Fertility Awareness-Based Methods
- Appendix G: Lactational Amenorrhea Method
- Appendix H: Coitus Interruptus (Withdrawal)
- Appendix I: Permanent Contraception
- Appendix J: Classifications for Emergency Contraception
- Appendix K: Summary of Classifications for Hormonal Contraceptive Methods and Intrauterine Devices
- Personal characteristics and reproductive history
- Cardiovascular disease
- Renal disease
- Rheumatic diseases
- Neurologic conditions
- Depressive disorders
- Reproductive tract infections and disorders
- HIV
- Other infections
- Endocrine conditions
- Gastrointestinal conditions
- Respiratory conditions
- Hematologic conditions
- Solid organ transplantation
- Drug interactions
- Personal characteristics and reproductive history
- Acknowledgments, Contributors, and Participants